EA201591218A1 - Способы и композиции для введения оксибутинина - Google Patents

Способы и композиции для введения оксибутинина

Info

Publication number
EA201591218A1
EA201591218A1 EA201591218A EA201591218A EA201591218A1 EA 201591218 A1 EA201591218 A1 EA 201591218A1 EA 201591218 A EA201591218 A EA 201591218A EA 201591218 A EA201591218 A EA 201591218A EA 201591218 A1 EA201591218 A1 EA 201591218A1
Authority
EA
Eurasian Patent Office
Prior art keywords
salt
agents
compositions
methods
oxybutynin
Prior art date
Application number
EA201591218A
Other languages
English (en)
Inventor
Роберт Кук
Дэвид А. Байрон
Скотт Флеминг
Original Assignee
Майкродоуз Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/728,706 external-priority patent/US9119777B2/en
Application filed by Майкродоуз Терапьютикс, Инк. filed Critical Майкродоуз Терапьютикс, Инк.
Publication of EA201591218A1 publication Critical patent/EA201591218A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение касается способов и композиций для лечения заболевания легких, включающих доставку непосредственно в легкие пациента терапевтически эффективного количества оксибутинина в комбинации с одним или более фармацевтически эффективными средствами. Оксибутинин может быть выбран из группы, состоящей, но не в порядке ограничения, из ксинафоатной соли, пальмитатной соли, соли памовой кислоты, резинатной соли, лауратной соли и других солей. Фармацевтически эффективные средства включают бронходилататоры, противовоспалительные средства, кортикостероиды, средство для реверсии действия кортикостероидов или средства альвеолярного роста или другие средства, выбираемые из ингибиторов протеиназы или протеазы.
EA201591218A 2012-12-27 2013-12-12 Способы и композиции для введения оксибутинина EA201591218A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/728,706 US9119777B2 (en) 2008-05-30 2012-12-27 Methods and compositions for administration of oxybutynin
PCT/US2013/074759 WO2014105446A1 (en) 2012-12-27 2013-12-12 Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number Publication Date
EA201591218A1 true EA201591218A1 (ru) 2015-11-30

Family

ID=51021931

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591218A EA201591218A1 (ru) 2012-12-27 2013-12-12 Способы и композиции для введения оксибутинина

Country Status (15)

Country Link
EP (1) EP2938329A4 (ru)
JP (1) JP2016504358A (ru)
KR (1) KR20150100902A (ru)
CN (1) CN104955444A (ru)
AR (1) AR094287A1 (ru)
AU (1) AU2013368298B2 (ru)
BR (1) BR112015015421A2 (ru)
CA (1) CA2895955A1 (ru)
EA (1) EA201591218A1 (ru)
HK (2) HK1215396A1 (ru)
IL (1) IL239623A0 (ru)
MX (1) MX2015008333A (ru)
NZ (1) NZ628479A (ru)
UY (1) UY35230A (ru)
WO (1) WO2014105446A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190046493A1 (en) * 2016-02-25 2019-02-14 Hisamitsu Pharmaceutical Co., Inc. Liquid external preparation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003500354A (ja) * 1999-05-20 2003-01-07 セプラコール， インク． Ｓ−オキシブチニンを用いる喘息の治療方法
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
AU2003267796A1 (en) * 2002-10-29 2004-05-25 Pharmacia & Upjohn Company Llc Quaternary ammonium compounds
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
EP1817034A1 (en) * 2004-10-25 2007-08-15 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
EP3311820A1 (en) * 2008-02-26 2018-04-25 Sunovion Respiratory Development Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
AU2010260513A1 (en) * 2009-06-16 2012-02-02 Wen Tan Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
CN102858326A (zh) * 2010-04-01 2013-01-02 奇斯药制品公司 用于制备可吸入干粉所用的载体颗粒的方法
EP2621588A4 (en) * 2010-09-27 2014-09-03 Microdose Therapeutx Inc METHODS AND COMPOSITIONS FOR TREATING DISEASE USING INHALATION

Also Published As

Publication number Publication date
CN104955444A (zh) 2015-09-30
AU2013368298B2 (en) 2016-08-11
IL239623A0 (en) 2015-08-31
CA2895955A1 (en) 2014-07-03
BR112015015421A2 (pt) 2017-07-11
NZ628479A (en) 2016-06-24
MX2015008333A (es) 2015-11-09
EP2938329A4 (en) 2016-08-10
JP2016504358A (ja) 2016-02-12
HK1216843A1 (zh) 2016-12-09
EP2938329A1 (en) 2015-11-04
KR20150100902A (ko) 2015-09-02
AU2013368298A1 (en) 2015-07-02
UY35230A (es) 2015-01-30
WO2014105446A1 (en) 2014-07-03
HK1215396A1 (zh) 2016-08-26
AR094287A1 (es) 2015-07-22

Similar Documents

Publication Publication Date Title
CY1120049T1 (el) (2s)-ν-[(1s)-1-κυανο-2-φαινυλαιθυλ]-1,4-οξαζεπαν-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης i
SG10201909122QA (en) Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
EA201590371A1 (ru) 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний
MX369385B (es) Productos para cicatrizar heridas tisulares.
WO2016004093A3 (en) Therapeutic compositions including galectin-3 inhibitors and uses thereof
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
BR112015001419A2 (pt) composto, composição farmacêutica, e, métodos para inibir romk em um paciente, para causar diurese, natriurese ou ambos e para tratamento de um ou mais distúrbios
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
RU2013121788A (ru) Ингибиторы репликации вич
JP2013520405A5 (ru)
MX2017000612A (es) Inhibidores de tirosina quinasa del bazo (syk).
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
BR112013029246A2 (pt) 4-amino-5-flúor-3-[6- (4-metilpiperazin- 1 - il) - 1h - benzimidazol - 2 - il] - 1h - quinolin-2-ona para uso no tratamento de carcinoma adenoide cístico
WO2015183963A3 (en) Therapeutic compositions including redox-active parabenzoquinones and uses thereof
EA201490254A1 (ru) Комбинированное лечение гепатита с
MX2020010300A (es) Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas.
WO2015157559A3 (en) 10',11'-modified saxitoxins useful for the treatment of pain
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
BR112014010729A2 (pt) métodos para tratamento de ataques de gota
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
EA201490573A1 (ru) Соединение бензотиазолона
BR112014002885A2 (pt) uso de composto orgânico para o tratamento da síndrome de noonan